Last reviewed · How we verify

NCT07030634

Blood Flow Restriction and Proprioception Training on Ankle Joint Sensations

Not yet recruiting NA Last updated 22 June 2025
What this trial tests

NA trial testing conventional physical therapy in Lateral Ankle Sprain in 60 participants. Not yet recruiting.

Timeline
15 June 2025
Primary endpoint
1 August 2025
20 August 2025

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date15 June 2025
Primary completion1 August 2025
Estimated completion20 August 2025

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 30, any sex, with Lateral Ankle Sprain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Thirty-four participants with grade I and II recurrent ankle sprain, were referred from orthopaedic physician. Their ages ranged from 20 to 30 years old. All participants will be divided randomly into two groups A, B. Seventeen participants per group. Participant selected from both sexes, with body mass index between 18 and 24.9 Kg/m², with self-reported history of at least one significant lateral ankle sprain (LAS) greater than 12 months prior to testing and recurring ankle sprains, ankle "giving way" and/or "feelings of instability". Participants with previous surgery or fracture and with any adverse effects to blood occlusion will be excluded.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of conventional physical therapy

Trials testing the same drug.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07030634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing